Cargando…

Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy

Tumor treatment is still complicated in the field of medicine. Tumor immunotherapy has been the most interesting research field in cancer therapy. Application of chimeric antigen receptor T (CAR-T) cell therapy has recently achieved excellent clinical outcome in patients, especially those with CD19-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Yanyu, Hou, Xiaoyang, Yang, Chunsheng, Liu, Yanqun, Jiang, Guan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956614/ https://www.ncbi.nlm.nih.gov/pubmed/29769134 http://dx.doi.org/10.1186/s12943-018-0840-y

Ejemplares similares

Core-shell type thermo-nanoparticles loaded with temozolomide combined with photothermal therapy in melanoma cells
por: Hou, Xiaoyang, et al.
Publicado: (2019)

CD44-Targeting Oxygen Self-Sufficient Nanoparticles for Enhanced Photodynamic Therapy Against Malignant Melanoma
por: Hou, Xiaoyang, et al.
Publicado: (2020)

Photoprotection of Cerium Oxide Nanoparticles against UVA radiation-induced Senescence of Human Skin Fibroblasts due to their Antioxidant Properties
por: Li, Yaxi, et al.
Publicado: (2019)

The Role of Toll-Like Receptors in Oncotherapy
por: Liu, Caiqi, et al.
Publicado: (2019)

Research advances in chimeric antigen receptor-modified T-cell therapy (Review)
por: Luo, Yuxi, et al.
Publicado: (2021)

Near-Infrared Light-Triggered Thermosensitive Liposomes Modified with Membrane Peptides for the Local Chemo/Photothermal Therapy of Melanoma
por: Li, Xinxin, et al.
Publicado: (2021)

From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy
por: Liu, Hanmeng, et al.
Publicado: (2023)

Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy
por: Li, Jianmin, et al.
Publicado: (2023)

Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
por: Dai, Hanren, et al.
Publicado: (2016)

Drugging SUMOylation for neuroprotection and oncotherapy
por: Bernstock, Joshua D., et al.
Publicado: (2018)

PKM2 in carcinogenesis and oncotherapy
por: He, Xia, et al.
Publicado: (2017)

Proarrhythmia and Oncotherapy: So Much To Be Done!
por: Kovacs, Richard J.
Publicado: (2021)

Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors
por: Zhang, Erhao, et al.
Publicado: (2018)

Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
por: Zou, Yixin, et al.
Publicado: (2018)

Advances Of Chimeric Antigen Receptor T Cell Therapy In Ovarian Cancer
por: Yan, Wenying, et al.
Publicado: (2019)

Chimeric antigen receptor modified T-cells for cancer treatment
por: Han, Xiao, et al.
Publicado: (2018)

Insights on CXC chemokine receptor 2 in breast cancer: An emerging target for oncotherapy
por: Guo, Fengzhu, et al.
Publicado: (2019)

Engineering chimeric antigen receptor-T cells for cancer treatment
por: Ye, Baixin, et al.
Publicado: (2018)

Chimeric antigen receptor T-cell therapy
por: Burge, Cale, et al.
Publicado: (2023)

Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors
por: Yan, Lingli, et al.
Publicado: (2018)

Galunisertib enhances chimeric antigen receptor-modified T cell function
por: Wang, Zhixiong, et al.
Publicado: (2020)

Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
por: Ren, Jiangtao, et al.
Publicado: (2017)

Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia
por: Marvin-Peek, Jennifer, et al.
Publicado: (2022)

Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies
por: Totzeck, Matthias, et al.
Publicado: (2022)

Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen
por: Timmers, Marijke, et al.
Publicado: (2019)

Efficient derivation of chimeric-antigen receptor-modified T(SCM) cells
por: Kranz, Emiko, et al.
Publicado: (2022)

Overcoming Chimeric Antigen Receptor (CAR) Modified T-Cell Therapy Limitations in Multiple Myeloma
por: García-Guerrero, Estefanía, et al.
Publicado: (2020)

Current Advances and Hurdles in Chimeric Antigen Receptor Technology
por: McComb, Scott, et al.
Publicado: (2020)

Chimeric Antigen Receptor T Cell Therapy in Hematology
por: Ataca, Pınar, et al.
Publicado: (2015)

Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
por: Khurana, Arushi, et al.
Publicado: (2022)

Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis
por: Reinhardt, Bryanna, et al.
Publicado: (2023)

Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine
por: Nam, Ju-Suk, et al.
Publicado: (2016)

Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
por: He, Rui, et al.
Publicado: (2020)

Chimeric antigen receptor T-cell therapy for T-ALL and AML
por: Wei, Wenwen, et al.
Publicado: (2022)

Amplifying mRNA vaccines: potential versatile magicians for oncotherapy
por: Hu, Chaoying, et al.
Publicado: (2023)

Nanoscale covalent organic frameworks as theranostic platforms for oncotherapy: synthesis, functionalization, and applications
por: Guan, Qun, et al.
Publicado: (2020)

Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL‐24 enhances the antitumor effect of temozolomide against melanoma
por: Yang, Ming, et al.
Publicado: (2018)

Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma
por: Ren, Pei-pei, et al.
Publicado: (2017)

Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells
por: Otáhal, Pavel, et al.
Publicado: (2015)

Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects
por: Guo, Yelei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_antpohec7vuh6tur963sq6qurv